|
Balsara, B. R., J. Pei, Y. Mitsuuchi, R. Page, A. Klein-Szanto, H. Wang, M. Unger and J. R. Testa (2004). "Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions." Carcinogenesis 25(11): 2053-2059.
Banai, S., D. Shweiki, A. Pinson, M. Chandra, G. Lazarovici and E. Keshet (1994). "Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis." Cardiovasc Res 28(8): 1176-1179.
Bauer, B., N. Krumbock, F. Fresser, F. Hochholdinger, M. Spitaler, A. Simm, F. Uberall, B. Schraven and G. Baier (2001). "Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells." J Biol Chem 276(34): 31627-31634.
Bauer, S., A. Duensing, G. D. Demetri and J. A. Fletcher (2007). "KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway." Oncogene 26(54): 7560-7568.
Bertolotto, C., L. Maulon, N. Filippa, G. Baier and P. Auberger (2000). "Protein kinase C theta and epsilon promote T-cell survival by a rsk-dependent phosphorylation and inactivation of BAD." J Biol Chem 275(47): 37246-37250.
Blancher, C., J. W. Moore, N. Robertson and A. L. Harris (2001). "Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3''-kinase/Akt signaling pathway." Cancer Res 61(19): 7349-7355.
Bonni, A., A. Brunet, A. E. West, S. R. Datta, M. A. Takasu and M. E. Greenberg (1999). "Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms." Science 286(5443): 1358-1362.
Cardone, M. H. (1998). "Regulation of Cell Death Protease Caspase-9 by Phosphorylation." Science 282(5392): 1318-1321.
Cardone, M. H., N. Roy, H. R. Stennicke, G. S. Salvesen, T. F. Franke, E. Stanbridge, S. Frisch and J. C. Reed (1998). "Regulation of cell death protease caspase-9 by phosphorylation." Science 282(5392): 1318-1321.
Chen, W. T., C. J. Huang, M. T. Wu, S. F. Yang, Y. C. Su and C. Y. Chai (2005). "Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor." Jpn J Clin Oncol 35(4): 207-213.
Cheng, Y., X. Ren, Y. Zhang, R. Patel, A. Sharma, H. Wu, G. P. Robertson, L. Yan, E. Rubin and J. M. Yang (2011). "eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206." Cancer Res 71(7): 2654-2663.
Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh and M. E. Greenberg (1997). "Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery." Cell 91(2): 231-241.
Duensing, A., N. E. Joseph, F. Medeiros, F. Smith, J. L. Hornick, M. C. Heinrich, C. L. Corless, G. D. Demetri, C. D. Fletcher and J. A. Fletcher (2004). "Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs)." Cancer Res 64(15): 5127-5131.
Duensing, A., F. Medeiros, B. McConarty, N. E. Joseph, D. Panigrahy, S. Singer, C. D. Fletcher, G. D. Demetri and J. A. Fletcher (2004). "Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)." Oncogene 23(22): 3999-4006.
Han, Z. B., H. Ren, H. Zhao, Y. Chi, K. Chen, B. Zhou, Y. J. Liu, L. Zhang, B. Xu, B. Liu, R. Yang and Z. C. Han (2008). "Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF)." Carcinogenesis 29(10): 1853-1861.
Heinrich, M. C., C. L. Corless, C. D. Blanke, G. D. Demetri, H. Joensuu, P. J. Roberts, B. L. Eisenberg, M. von Mehren, C. D. Fletcher, K. Sandau, K. McDougall, W. B. Ou, C. J. Chen and J. A. Fletcher (2006). "Molecular correlates of imatinib resistance in gastrointestinal stromal tumors." J Clin Oncol 24(29): 4764-4774.
Heinrich, M. C., C. L. Corless, A. Duensing, L. McGreevey, C. J. Chen, N. Joseph, S. Singer, D. J. Griffith, A. Haley, A. Town, G. D. Demetri, C. D. Fletcher and J. A. Fletcher (2003). "PDGFRA activating mutations in gastrointestinal stromal tumors." Science 299(5607): 708-710.
Hirano, K., Y. Shishido-Hara, A. Kitazawa, K. Kojima, A. Sumiishi, M. Umino, F. Kikuchi, A. Sakamoto, Y. Fujioka and H. Kamma (2008). "Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation." Pathol Res Pract 204(11): 799-807.
Hirota, S. (1998). "Gain-of-Function Mutations of c-kit in Human Gastrointestinal Stromal Tumors." Science 279(5350): 577-580.
Lee, Y., J. Jung, K. J. Cho, S. K. Lee, J. W. Park, I. H. Oh and G. J. Kim (2013). "Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR." J Cell Biochem 114(1): 79-88.
Litz, J. and G. W. Krystal (2006). "Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells." Mol Cancer Ther 5(6): 1415-1422.
Lux, M. L., B. P. Rubin, T. L. Biase, C.-J. Chen, T. Maclure, G. Demetri, S. Xiao, S. Singer, C. D. M. Fletcher and J. A. Fletcher (2000). "KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors." The American Journal of Pathology 156(3): 791-795.
Mabjeesh, N. J. and S. Amir (2007). "Hypoxia-inducible factor (HIF) in human tumorigenesis." Histol Histopathol 22(5): 559-572.
Monsel, G., N. Ortonne, M. Bagot, A. Bensussan and N. Dumaz (2010). "c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes." Oncogene 29(2): 227-236.
Ou, W. B., M. J. Zhu, G. D. Demetri, C. D. Fletcher and J. A. Fletcher (2008). "Protein kinase C-theta regulates KIT expression and proliferation in gastrointestinal stromal tumors." Oncogene 27(42): 5624-5634.
Poon, E., A. L. Harris and M. Ashcroft (2009). "Targeting the hypoxia-inducible factor (HIF) pathway in cancer." Expert Rev Mol Med 11: e26.
Pore, N., Z. Jiang, H. K. Shu, E. Bernhard, G. D. Kao and A. Maity (2006). "Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway." Mol Cancer Res 4(7): 471-479.
Rubin, B. P., S. Singer, C. Tsao, A. Duensing, M. L. Lux, R. Ruiz, M. K. Hibbard, C. J. Chen, S. Xiao, D. A. Tuveson, G. D. Demetri, C. D. Fletcher and J. A. Fletcher (2001). "KIT activation is a ubiquitous feature of gastrointestinal stromal tumors." Cancer Res 61(22): 8118-8121.
Scheid, M. P., K. M. Schubert and V. Duronio (1999). "Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase." J Biol Chem 274(43): 31108-31113.
Schmid, T., J. Zhou, R. Kohl and B. Brune (2004). "p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1)." Biochem J 380(Pt 1): 289-295.
Stegeman, H., J. H. Kaanders, D. L. Wheeler, A. J. van der Kogel, M. M. Verheijen, S. J. Waaijer, M. Iida, R. Grenman, P. N. Span and J. Bussink (2012). "Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck." BMC Cancer 12: 463.
Theou-Anton, N., S. Tabone, D. Brouty-Boye, R. Saffroy, L. Ronnstrand, A. Lemoine and J. F. Emile (2006). "Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism." Br J Cancer 94(8): 1180-1185.
Tsujimoto, Y. and S. Shimizu (2005). "Another way to die: autophagic programmed cell death." Cell Death Differ 12 Suppl 2: 1528-1534.
Turner, K. J., J. W. Moore, A. Jones, C. F. Taylor, D. Cuthbert-Heavens, C. Han, R. D. Leek, K. C. Gatter, P. H. Maxwell, P. J. Ratcliffe, D. Cranston and A. L. Harris (2002). "Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation." Cancer Res 62(10): 2957-2961.
Tuveson, D. A., N. A. Willis, T. Jacks, J. D. Griffin, S. Singer, C. D. Fletcher, J. A. Fletcher and G. D. Demetri (2001). "STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications." Oncogene 20(36): 5054-5058.
Uchiyama, T., R. M. Engelman, N. Maulik and D. K. Das (2004). "Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning." Circulation 109(24): 3042-3049.
Wouters, B. G. and M. Koritzinsky (2008). "Hypoxia signalling through mTOR and the unfolded protein response in cancer." Nat Rev Cancer 8(11): 851-864.
Wu, X., J. Li, M. Zhu, J. A. Fletcher and F. S. Hodi (2012). "Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-kappaB pathways." Mol Cancer Ther 11(9): 1905-1914.
Yang, Z. J., C. E. Chee, S. Huang and F. A. Sinicrope (2011). "The role of autophagy in cancer: therapeutic implications." Mol Cancer Ther 10(9): 1533-1541.
Zhang, W. and H. T. Liu (2002). "MAPK signal pathways in the regulation of cell proliferation in mammalian cells." Cell Res 12(1): 9-18.
Zhong, H., F. Agani, A. A. Baccala, E. Laughner, N. Rioseco-Camacho, W. B. Isaacs, J. W. Simons and G. L. Semenza (1998). "Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer." Cancer Res 58(23): 5280-5284.
Zhu, M. J., W. B. Ou, C. D. Fletcher, P. S. Cohen, G. D. Demetri and J. A. Fletcher (2007). "KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance." Oncogene 26(44): 6386-6395.
|